Drug Database
Back to search

Netherlands· NL-0015a385cf52

Tobrex, oogzalf 0,3%

A tobramycin product containing tobramycine, registered in Netherlands by Novartis Pharma B.V.. The same ATC class is registered in 10 of our 19 countries.

ATC S01AA12

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTobrex, oogzalf 0,3%ATCS01AA12REGISTER NO.NL-0015a385cf52PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tobramycineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tobramycin is registered in 10 of 19 countries.

Countries holding a registration under ATC S01AA12 (tobramycin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search tobramycin products by name

Tobramycin · ATC S01AA12

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TOBRAMYCINE
Manufacturer
Novartis Pharma B.V.
Country
Netherlands (NL)
ATC code
S01AA12
ATC class
Tobramycin
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    10225

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tobramycin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tobramycin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Bramitob, Tobi
  • Belgium · Obracin, Tobi
  • Bulgaria · Tобрекс, Тобрамизил
  • Cyprus · Bramitob, Ikobel
  • Czechia · Bramitob, Tobramycin Vioser
  • Germany · Bramitob, Gernebcin
  • Denmark · Nebcina, Tobi
  • Estonia · Tobramycin Via Pharma, Tobrex
  • Spain · Bramitob, Tobrabact
  • Finland · Tobi
  • France · Nebcine, Tobi
  • United Kingdom (Northern Ireland) · Bramitob, Munuza
  • Greece · Bramitob, Eyetobrin
  • Croatia · Bramitob, Tobrex
  • Hungary · Bramitob, Brulamycin
  • Ireland · Bramitob, Tobi
  • Iceland · Tobi Podhaler, Vantobra
  • Italy · Bramicil, Bramitob
  • Liechtenstein · Tobi Podhaler, Vantobra
  • Lithuania · Bramitob, Tobramycin Via Pharma
  • Luxembourg · Obracin, Tobi
  • Latvia · Bramitob, Tobramycin Via Pharma
  • Malta · Tobi, Tobrex
  • Norway · Bramitob, Nebcina
  • Poland · Bramitob, Tobramycin Via Pharma
  • Portugal · Bramitob, Tobi
  • Romania · Tobi, Tobramicină Sun
  • Sweden · Bramitob, Nebcina
  • Slovenia · Tobrex
  • Slovakia · Bramitob, Tobrex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/79aae608-575a-4981-abca-e1f65dbf341d
GET /v1/drugs/79aae608-575a-4981-abca-e1f65dbf341d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogzalf",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h10225_smpc.pdf",
  "strength": null,
  "atc_label": "Tobramycin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg10225",
  "excipients": [
    "CHLOORBUTANOL 0-WATER",
    "PARAFFINE, VLOEIBAAR (E905)",
    "PARAFFINE, ZACHT (E 905)"
  ],
  "substances": [
    "TOBRAMYCINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h10225.pdf",
  "authorised_at": "1984/12/04",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "10225",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about tobramycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console